Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial

This analysis assessed whether responses with exenatide once weekly plus dapagliflozin (n = 231), exenatide once weekly alone (n = 230), or dapagliflozin alone (n = 233) differed in key patient subpopulations of the DURATION‐8 trial. Potential treatment‐by‐subgroup interactions for changes in glycat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Frías, Juan P., Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter, Jabbour, Serge, Wang, Hui, Guja, Cristian
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2018
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5969323/
https://ncbi.nlm.nih.gov/pubmed/29573139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13296
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars